-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FyFzITMSa3Ynj9KXArQcHG3opvzn+zZmvwnGZdemfq396hmAHUlpXYamL5rycBGy STZ2vkZVvbGZ89xc9c8P8w== 0001209191-06-018483.txt : 20060317 0001209191-06-018483.hdr.sgml : 20060317 20060317141938 ACCESSION NUMBER: 0001209191-06-018483 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060315 FILED AS OF DATE: 20060317 DATE AS OF CHANGE: 20060317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EISENBERG JEFFREY F CENTRAL INDEX KEY: 0001224096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17254 FILM NUMBER: 06695273 BUSINESS ADDRESS: STREET 1: C/O NOVEN PHARMACEUTICALS INC STREET 2: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-03-15 0 0000815838 NOVEN PHARMACEUTICALS INC NOVN 0001224096 EISENBERG JEFFREY F C/O NOVEN PHARMACEUTICALS, INC. 11960 S.W. 144TH STREET MIAMI FL 33186 0 1 0 0 Sr. VP - Strategic Alliances Common Stock ($.0001 Par Value) 2006-03-15 4 M 0 9500 8.81 A 12900 D Common Stock ($.0001 Par Value) 2006-03-15 4 S 0 3500 17.28 D 9400 D Common Stock ($.0001 Par Value) 2006-03-15 4 S 0 2000 17.31 D 7400 D Common Stock ($.0001 Par Value) 2006-03-15 4 S 0 4000 17.3626 D 3400 D Stock Options (Right to Buy) 8.81 2006-03-15 4 M 0 9500 0.00 D 2006-10-04 Common Stock ($ .0001 Par Value) 9500 5100 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2006. 10% exercisable after 10/05/2000; 20% exercisable after 10/05/2001; 20% exercisable after 10/05/2002; 25% exercisable after 10/05/2003; 25% exercisable after 10/05/2004. /s/ Jeffrey F. Eisenberg 2006-03-17 -----END PRIVACY-ENHANCED MESSAGE-----